Sildenafil Tablet, Film Coated
Product Images NDC 71335-1777

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 71335-1777). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure Of Sildenafil Citrate (Image 1)

Chemical Structure Of Sildenafil Citrate (Image 1)
Chemical structure of sildenafil, showing its molecular components and bonds, including a sulfonyl group, methylated nitrogen atoms, and a carboxylic acid moiety.*
FDA Label Image

Figure1 (Image 2)

Figure1 (Image 2)
A line graph comparing systolic blood pressure changes (in mmHg) over 24 hours post-dose between Sildenafil 100 mg and a placebo. The x-axis represents time post-dose in hours, and the y-axis shows changes in systolic blood pressure. Data points for both treatments are plotted and connected by lines for trend visualization.*
FDA Label Image

Figure2 (Image 3)

Figure2 (Image 3)
A line graph displaying the change in systolic blood pressure (mm Hg) over time (hours) postdose, comparing the effects of Doxazosin with Placebo and Doxazosin with Sildenafil 25 mg. The x-axis represents time in hours from 0 to 8, and the y-axis shows changes in blood pressure ranging from -40 to 20 mm Hg.*
FDA Label Image

Figure3 (Image 4)

Figure3 (Image 4)
A line graph comparing the change in systolic blood pressure (SBP) over time postdose (hours) between two treatments: Doxazosin plus placebo and Doxazosin plus Sildenafil 50 mg. The y-axis represents the change in SBP in mmHg, ranging from -50 to 40, and the x-axis represents time in hours from 0 to 8. The graph shows two distinct curves for each treatment group.*
FDA Label Image

Figure4 (Image 5)

Figure4 (Image 5)
A line chart showing the change in blood pressure (mmHg) over time (hours) after dosing for two groups: Doxazosin with Sildenafil 100 mg and Doxazosin with Placebo. The x-axis represents time after dosing from 0 to 8 hours, and the y-axis reflects blood pressure changes ranging from -50 to 40 mmHg.*
FDA Label Image

Figure5 (Image 6)

Figure5 (Image 6)
A line graph showing plasma concentrations (ng/mL) of sildenafil over time post dose in hours. The x-axis represents time from 0 to 24 hours, and the y-axis shows plasma concentration from 0 to 500 ng/mL. Data points connected by a line illustrate concentration changes following administration of a commercial tablet.*
FDA Label Image

Figure6 (Image 7)

Figure6 (Image 7)
Two bar charts display the effect of Sildenafil Citrate and placebo on maintenance of erection by baseline score. The vertical axes represent the percentage of patients at endpoint, while the horizontal axes represent baseline scores from 0 to 5. Different bars in each group correspond to varying response categories, showing comparative patient outcomes for each baseline score under both Sildenafil and placebo conditions.*
FDA Label Image

Figure7 (Image 8)

Figure7 (Image 8)
A bar chart depicting the percentage of patients reporting improvement across four treatment groups: Placebo (24%), Sildenafil 25 mg (63%), Sildenafil 50 mg (74%), and Sildenafil 100 mg (82%). The chart shows increasing improvement with higher Sildenafil doses.*
FDA Label Image

Label (Lbl713351777)

Label (Lbl713351777)
Label for Sildenafil Citrate 100 mg film-coated tablet by Bryant Ranch Prepack. The label states it is comparable to Viagra 100 mg tablet and includes storage instructions to keep at room temperature (20°-25°C) and out of reach of children. It displays the NDC 71335-1777 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.